{"id":385180,"date":"2020-11-19T09:07:10","date_gmt":"2020-11-19T14:07:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=385180"},"modified":"2020-11-19T09:07:10","modified_gmt":"2020-11-19T14:07:10","slug":"salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/","title":{"rendered":"Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">Scientific Poster Examines Effects of Treatment in Cancer and Non-Cancer Patients with Opioid-Induced Constipation<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">BRIDGEWATER, N.J.<\/span>, <span class=\"xn-chron\">Nov. 19, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0Salix Pharmaceuticals (&#8220;Salix&#8221;), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced that a scientific poster featuring methylnaltrexone\u00a0data received a\u00a0Best of Meeting Award\u00a0from the American Society of Regional Anesthesia and Pain Medicine (ASRA) at its\u00a019<sup>th<\/sup>\u00a0Annual Pain Medicine Meeting<b>,<\/b>\u00a0which will be held virtually <span class=\"xn-chron\">Nov. 20-22, 2020<\/span>. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg\" title=\"Salix Pharmaceuticals, Ltd. Logo (PRNewsfoto\/Salix Pharmaceuticals, Ltd.)\" alt=\"Salix Pharmaceuticals, Ltd. Logo (PRNewsfoto\/Salix Pharmaceuticals, Ltd.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>&#8220;Salix is honored to be recognized by ASRA for a Best of Meeting Award, a distinction that is reserved for the highest scoring scientific abstracts. Our scientific poster presentation includes analyses examining the effects of subcutaneous methylnaltrexone in cancer and non-cancer patients with opioid-induced constipation,&#8221;\u00a0said <span class=\"xn-person\">Howard Franklin<\/span>, M.D., chief medical officer, Salix. <\/p>\n<p>The Salix abstract will be available via the ASRA online portal beginning <span class=\"xn-chron\">Nov. 21<\/span>:<\/p>\n<ul type=\"disc\">\n<li>Shah, Eric. &#8220;Subcutaneous Methylnaltrexone in Cancer and Noncancer Patients for Rapid Relief of Opioid-Induced Constipation.&#8221;\u00a0Abstract #1347; <span class=\"xn-chron\">Saturday, Nov. 21<\/span>, <span class=\"xn-chron\">12:00 pm ET<\/span>.<\/li>\n<\/ul>\n<p>\n        <b>About Salix<br \/><\/b>Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases. For more than 30 years, Salix has licensed, developed, and marketed innovative products to improve patients&#8217; lives and arm health care providers with life-changing solutions for many chronic and debilitating conditions. Salix currently markets its product line to U.S. health care providers through an expanded sales force that focuses on gastroenterology, hepatology, pain specialists and primary care. Salix is headquartered in <span class=\"xn-location\">Bridgewater, New Jersey<\/span>. For more information about Salix, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2987081-1&amp;h=1266736356&amp;u=http%3A%2F%2Fwww.salix.com%2F&amp;a=www.Salix.com\" rel=\"nofollow noopener noreferrer\">www.Salix.com<\/a>\u00a0and connect with us on <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2987081-1&amp;h=2116953167&amp;u=https%3A%2F%2Ftwitter.com%2Fsalixpharma%3Flang%3Den&amp;a=Twitter\" rel=\"nofollow noopener noreferrer\">Twitter<\/a>\u00a0and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2987081-1&amp;h=2076869811&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsalix-pharmaceuticals%2F&amp;a=LinkedIn\" rel=\"nofollow noopener noreferrer\">LinkedIn<\/a>.<\/p>\n<p>SAL.0184.USA.20<br \/>\u00a92020 Salix Pharmaceuticals or its affiliates.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY97163&amp;sd=2020-11-19\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting-301177117.html\">http:\/\/www.prnewswire.com\/news-releases\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting-301177117.html<\/a><\/p>\n<p>SOURCE  Salix Pharmaceuticals, Ltd.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY97163&amp;Transmission_Id=202011190904PR_NEWS_USPR_____NY97163&amp;DateId=20201119\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientific Poster Examines Effects of Treatment in Cancer and Non-Cancer Patients with Opioid-Induced Constipation PR Newswire BRIDGEWATER, N.J., Nov. 19, 2020 \/PRNewswire\/ &#8212;\u00a0Salix Pharmaceuticals (&#8220;Salix&#8221;), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced that a scientific poster featuring methylnaltrexone\u00a0data received a\u00a0Best of Meeting Award\u00a0from the American Society of Regional Anesthesia and Pain Medicine (ASRA) at its\u00a019th\u00a0Annual Pain Medicine Meeting,\u00a0which will be held virtually Nov. 20-22, 2020. &#8220;Salix is honored to be recognized by ASRA for a Best of Meeting Award, a distinction that is reserved for the highest scoring scientific abstracts. Our scientific poster presentation includes analyses examining the effects of subcutaneous methylnaltrexone in cancer and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-385180","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Salix&#039;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#039;s Annual Pain Medicine Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salix&#039;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#039;s Annual Pain Medicine Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Scientific Poster Examines Effects of Treatment in Cancer and Non-Cancer Patients with Opioid-Induced Constipation PR Newswire BRIDGEWATER, N.J., Nov. 19, 2020 \/PRNewswire\/ &#8212;\u00a0Salix Pharmaceuticals (&#8220;Salix&#8221;), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced that a scientific poster featuring methylnaltrexone\u00a0data received a\u00a0Best of Meeting Award\u00a0from the American Society of Regional Anesthesia and Pain Medicine (ASRA) at its\u00a019th\u00a0Annual Pain Medicine Meeting,\u00a0which will be held virtually Nov. 20-22, 2020. &#8220;Salix is honored to be recognized by ASRA for a Best of Meeting Award, a distinction that is reserved for the highest scoring scientific abstracts. Our scientific poster presentation includes analyses examining the effects of subcutaneous methylnaltrexone in cancer and &hellip; Continue reading &quot;Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-19T14:07:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting\",\"datePublished\":\"2020-11-19T14:07:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/551702\\\/Salix_Pharmaceuticals_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/\",\"name\":\"Salix's Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA's Annual Pain Medicine Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/551702\\\/Salix_Pharmaceuticals_Logo.jpg\",\"datePublished\":\"2020-11-19T14:07:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/551702\\\/Salix_Pharmaceuticals_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/551702\\\/Salix_Pharmaceuticals_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Salix's Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA's Annual Pain Medicine Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Salix's Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA's Annual Pain Medicine Meeting - Market Newsdesk","og_description":"Scientific Poster Examines Effects of Treatment in Cancer and Non-Cancer Patients with Opioid-Induced Constipation PR Newswire BRIDGEWATER, N.J., Nov. 19, 2020 \/PRNewswire\/ &#8212;\u00a0Salix Pharmaceuticals (&#8220;Salix&#8221;), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced that a scientific poster featuring methylnaltrexone\u00a0data received a\u00a0Best of Meeting Award\u00a0from the American Society of Regional Anesthesia and Pain Medicine (ASRA) at its\u00a019th\u00a0Annual Pain Medicine Meeting,\u00a0which will be held virtually Nov. 20-22, 2020. &#8220;Salix is honored to be recognized by ASRA for a Best of Meeting Award, a distinction that is reserved for the highest scoring scientific abstracts. Our scientific poster presentation includes analyses examining the effects of subcutaneous methylnaltrexone in cancer and &hellip; Continue reading \"Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-19T14:07:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting","datePublished":"2020-11-19T14:07:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/"},"wordCount":315,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/","name":"Salix's Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA's Annual Pain Medicine Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg","datePublished":"2020-11-19T14:07:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/551702\/Salix_Pharmaceuticals_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/salixs-methylnaltrexone-abstract-wins-best-of-meeting-award-at-asras-annual-pain-medicine-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Salix&#8217;s Methylnaltrexone Abstract Wins Best Of Meeting Award At ASRA&#8217;s Annual Pain Medicine Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/385180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=385180"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/385180\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=385180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=385180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=385180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}